Close Menu

Despite the financial crisis, industrial biotechnology "is taking off," writes The Economist. This sector is doing well, the article says, because the technology has matured beyond the laboratory stage and large corporations are beginning to take advantage of it. Indeed, a few startups that are now being backed by larger firms: Royal Dutch Shell has invested in Codexis and the French oil company Total is backing Amyris. "We're not just dealing with vats any more," says Volkert Claassen of Royal DSM.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.